Autor segons l'article: Resino, Salvador; Jimenez-Sousa, Maria Angeles; Blanco, Julia; Pacheco, Yolanda M.; del Romero, Jorge; Peraire, Joaquim; Virseda-Berdices, Ana; Munoz-Gomez, Maria Jose; Galera-Penaranda, Carlos; Garcia-Fraile, Lucio Jesus; Benito, Jose M.; Rallon, Norma;Epiclin, SARNPR
Departament: Medicina i Cirurgia
Autor/s de la URV: Peraire Forner, José Joaquin
Paraules clau: Vitamin T-cell recovery Snp Liver fibrosis Infected patients Immune reconstitution Hiv Disease progression Dhcr7 Dbp D-receptor gene D-binding protein D serum-levels Common genetic-determinants Cd4(+) t cells Antiretroviral therapy 25-hydroxyvitamin d
Resum: Background: The lack of the recovery of CD4(+) T-cells (CD4(+) recovery) among immunodeficiency virus (HIV)-infected patients on antiretroviral therapy (ART) is not well known. We aimed to analyze the association between single nucleotide polymorphisms (SNPs) underlying vitamin D metabolism and the CD4(+) recovery in naive HIV-infected patients who started ART with low baseline CD4(+).Methods: We conducted a retrospective study in 411 naive individuals with plasma HIV load >200 copies/mL and CD4(+) <200 cells/mm(3). During 24 months of follow-up, all patients had plasma HIV load Results: CD4(+) recovery was higher in patients carrying DBP rs7041 AA genotype (AA versus CC/AC) and DHCR7 rs3829251 AA genotype (AA versus GG/AG) (p-value < 0.05). DBP rs7041 AA genotype was linked to increase in CD4(+) (adjusted arithmetic mean ratio (aAMR) = 1.22; q-value = 0.011), increase in CD4(+) >= P75th [adjusted odds ratio (aOR) = 2.31; q-value = 0.005], slope of CD4(+) recovery (aAMR = 1.25; q-value = 0.008), slope of CD4(+) recovery >= P75th (aOR = 2.55; q-value = 0.005) and achievement of CD4(+) >= 500 cells/mm(3) (aOR = 1.89; q-value = 0.023). Besides, DHCR7 rs3829251 AA genotype was related to increase in CD4(+) (aAMR = 1.43; q-value = 0.031), increase in CD4(+) >= P75th (aOR = 3.92; q-value = 0.030), slope of CD4(+) recovery (aAMR = 1.40; q-value = 0.036), slope of CD4(+) recovery >= P75th (aOR = 3.42; q-value = 0.031) and achievement of CD4(+) >= 500 cells/mm(3) (aOR = 5.68; q-value = 0.015).Conclusion: In summary, DHCR7 rs3829251 and DBP rs7041 polymorphisms were associated with CD4(+) recovery in HIV-infected patients who started cART with low CD4(+) T-cell counts.
Àrees temàtiques: Psicología Pharmacology (medical) Pharmacology & pharmacy Pharmacology Odontología Medicina veterinaria Medicina ii Medicina i Interdisciplinar Farmacia Ciências biológicas iii Ciências biológicas ii Ciências biológicas i Biotecnología Biodiversidade
Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
Adreça de correu electrònic de l'autor: joaquim.peraire@urv.cat
Identificador de l'autor: 0000-0001-7808-5479
Data d'alta del registre: 2024-09-07
Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
Referència a l'article segons font original: Frontiers In Pharmacology. 12
Referència de l'ítem segons les normes APA: Resino, Salvador; Jimenez-Sousa, Maria Angeles; Blanco, Julia; Pacheco, Yolanda M.; del Romero, Jorge; Peraire, Joaquim; Virseda-Berdices, Ana; Munoz- (2022). DBP rs7041 and DHCR7 rs3829251 are Linked to CD4(+) Recovery in HIV Patients on Antiretroviral Therapy. Frontiers In Pharmacology, 12(), -. DOI: 10.3389/fphar.2021.773848
Entitat: Universitat Rovira i Virgili
Any de publicació de la revista: 2022
Tipus de publicació: Journal Publications
Repositori URV